Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,438.00
+16.00 (1.13%)
Aug 20, 2026, 3:14 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.16 trillion as of August 20, 2026. Its market cap has decreased by -7.15% in one year.
Market Cap
1.16T
Enterprise Value
1.07T
Revenue
280.68B
Ranking
n/a
PE Ratio
34.48
Stock Price
1,438.00
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.16T, an increase of 76,644.84%. That is a compound annual growth rate of 24.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.16T | -4.84% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.25T |
| Zydus Lifesciences | 1.13T |
| Mankind Pharma | 983.30B |
| Laurus Labs | 976.98B |
| Aurobindo Pharma | 936.25B |
| Glenmark Pharmaceuticals | 654.25B |
| Alkem Laboratories | 642.54B |
| Gland Pharma | 480.09B |